Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases
In uveal melanoma patients with liver metastases, LV with a threshold for liver volume increase of 10% was suitable to evaluate treatment response and would be able to be used as a valuable add-on or even alternative to RECIST 1.1.
Authors
- Marcel Opitz (ORCID: https://orcid.org/0000-0001-7455-8590)
- Benedikt M. Schaarschmidt (ORCID: https://orcid.org/0000-0001-6331-7679)
- Johannes Haubold (ORCID: https://orcid.org/0000-0003-4843-5911)
- Heike Richly
- Sebastian Zensen (ORCID: https://orcid.org/0000-0003-2997-0740)
- Jens Thomas Siveke (ORCID: https://orcid.org/0000-0002-8772-4778)
- Michael Forsting (ORCID: https://orcid.org/0000-0002-5584-9824)
- Yan Li (ORCID: https://orcid.org/0000-0002-9403-9533)
- Aleksandar Milošević (ORCID: https://orcid.org/0000-0003-3601-3287)
- Hannah L Steinberg‐Vorhoff (ORCID: https://orcid.org/0000-0003-4848-4166)
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Essen University Hospital (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Radiology and Oncology
- Published
- 2024-11-28
- DOI
- https://doi.org/10.2478/raon-2024-0063
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Duisburg-Essen